Impact of Cardiovascular Risk Control on Racial Disparities in Kidney Transplant
Impact of Cardiovascular Risk Control on Racial Disparities in Kidney Transplant
批准号:
8698957
负责人:
David J. Taber
金额:
$16.69万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-04-01 至 2019-01-31
关键词:
AddressAdverse effectsApplications GrantsAreaAttentionAwardCardiovascular DiseasesCessation of lifeCohort StudiesDataData SetDevelopment PlansDiabetes MellitusDialysis procedureDrug KineticsDyslipidemiasEffectivenessEnvironmentEtiologyFundingGenotypeGoalsGraft SurvivalGrantHealth Services AccessibilityHypertensionImmune responseImmunologicsImmunosuppressive AgentsImprove AccessInequalityInterventionKidney TransplantationLeadLifeMeasuresMedicalMentorsMethodsModelingOutcomePatientsPharmaceutical PreparationsPharmacistsPhasePopulation StudyPositioning AttributePrevalenceProspective StudiesProviderRaceRandomized Controlled TrialsRegimenResearchResearch PersonnelRiskRisk FactorsRoleSocioeconomic StatusSouth CarolinaSurvival RateTestingTimeTrainingTransplant RecipientsTransplantationUniversitiescardiovascular disorder riskcardiovascular risk factorcareer developmentcohortcostdesigndiabetes controlexperiencegraft functionhigh riskimprovednovelpatient orientedpatient oriented researchpatient populationpublic health relevanceskillssocioeconomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The long-term goal of the applicant is to become an independent investigator who designs and executes studies to optimize medication utilization in kidney transplant patients, with the specific goals of reducing racial disparities in graft surviva. Black renal transplant recipients are at significantly higher risk for graft loss following kidney transplant due, in part, to well recognized immunologic hyper-responsiveness, poorer socioeconomic status and more severe comorbid conditions. Much of the previous interventions to reduce disparities in Black recipients have focused on improving access to transplant and reducing immunologic risks; yet the differences in graft survival rates between Black and non-Black kidney transplant patients have not significantly improved. To date, little attention has been directed towards improving CVD risk factor control as a potential approach to reduce racial disparities in kidney transplant. The proposed research plan will seek to test the hypothesis that CVD risk factor control significantly influences racial disparities in kidney transplant outcomes through a two phase study. Phase 1: a large-scale longitudinal cohort study conducted using national datasets (VA, CMS, and USRDS) that critically analyzes the modifying impact of CVD risk factor control on racial disparities among kidney transplants. Phase 2: The C-DRIFT trial (Cardiovascular Disease Risk Factor Control in Kidney Transplant) is a prospective study to explore the feasibility and potential effectiveness of pharmacist-led patient-level interventions directed at improving CVD risk factor control as a mechanism to reduce racial disparities in kidney transplant recipients. Completing these studies will provide novel and compelling preliminary data, so that by the conclusion of this award, a grant proposal will be submitted to conduct a large-scale randomized controlled trial powered to test the hypothesis that optimizing CVD risk factor control will improve graft survival and racial disparities in kidney transplant patients. Additionally and equally as important, the completion of this grant will provide the applicant invaluable training and mentoring that will allow him to develop the skillset necessary to become an independently funded investigator. The proposed career development plan capitalizes on the rich interdisciplinary collaborative environment, the unique patient population,
and the comprehensive didactic coursework available at the Medical University of South Carolina. The primary mentor and co-mentors on this application are highly experienced and well-funded researchers that have expertise in conducting research in racial disparities, kidney transplant and CVD interventional studies. Thus, at the conclusion of this award, novel data regarding the impact of CVD risk factor control on racial disparities in kidney transplant will be produced and disseminated while the applicant develops into a well-trained researcher, capable of conducing relevant patient-oriented research in kidney transplant recipients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multifaceted Intervention to Improve Graft Outcome Disparities in African American Kidney Transplants (MITIGAAT)
-
批准号:10729237
-
项目类别:
-
资助金额:$61.91万
-
财政年份:2023
-
负责人:David J. Taber
-
依托单位:
Improving Transplant Medication Safety through a TEchnology and Pharmacist (ISTEP) Intervention in Veterans
-
批准号:10186502
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:David J. Taber
-
依托单位:
Improving Transplant Medication Safety through a TEchnology and Pharmacist (ISTEP) Intervention in Veterans
-
批准号:9888963
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:David J. Taber
-
依托单位:
Improving Transplant Medication Safety through a TEchnology and Pharmacist (ISTEP) Intervention in Veterans
-
批准号:10376773
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:David J. Taber
-
依托单位:
Improving Transplant Med Safety through a Pharmacist-Led, mHealth-Based Program
-
批准号:9361634
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2017
-
负责人:David J. Taber
-
依托单位:
Impact of Cardiovascular Risk Control on Racial Disparities in Kidney Transplant
-
批准号:8998939
-
项目类别:
-
资助金额:$18.21万
-
财政年份:2014
-
负责人:David J. Taber
-
依托单位:
Impact of Cardiovascular Risk Control on Racial Disparities in Kidney Transplant
-
批准号:8815305
-
项目类别:
-
资助金额:$16.69万
-
财政年份:2014
-
负责人:David J. Taber
-
依托单位:
海外基金